STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow STE
STERIS plc (STE) EBITDA
STERIS plc's EBITDA for fiscal 2026 was $1.6B, up 18.3% from $1.3B in fiscal 2025. Over the twelve months to 30 June 2026 it was $1.6B. Over the past ten years it has ranged from $318.8M (fiscal 2015) to $1.6B (fiscal 2026) — the current reading is the highest in ten years. STERIS plc ranks 9th of 147 Medical Devices companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2026 | $1.6B | 18.28% |
| FY2025 | $1.3B | (4.50%) |
| FY2024 | $1.4B | 4.05% |
| FY2023 | $1.4B | 23.12% |
| FY2022 | $1.1B | 42.99% |
| FY2021 | $767.6M | 4.54% |
| FY2020 | $734.3M | 15.28% |
| FY2019 | $636.9M | 10.16% |
| FY2018 | $578.2M | 22.32% |
| FY2017 | $472.7M | 32.53% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $409.7M | (6.91%) |
| Mar 2026 | $440.1M | 11.33% |
| Dec 2025 | $395.3M | 2.01% |
| Sep 2025 | $387.5M | 6.05% |
| 42 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| PHG Koninklijke Philips N.V. compare | $3.4B |
| GEHC GE HealthCare Technologies Inc. compare | $3.3B |
| SNN Smith & Nephew SNATS, Inc. compare | $2.6B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $2.3B |
| STE STERIS plc | $1.6B |
| DXCM DexCom, Inc. compare | $1.4B |
| GMED Globus Medical, Inc. compare | $932.9M |
| PEN Penumbra, Inc. compare | $204.5M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $53.1M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on STE
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement